Page last updated: 2024-09-05

erlotinib hydrochloride and Cachexia

erlotinib hydrochloride has been researched along with Cachexia in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Agca, S; Arabaci, DH; Bilgic, SN; Domaniku, A; Kir, S; Weber, BZC	1
Fang, Z; Li, B; Zang, YS	1

Other Studies

2 other study(ies) available for erlotinib hydrochloride and Cachexia

Article	Year
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia. Journal of cachexia, sarcopenia and muscle, 2022, Volume: 13, Issue:3 Topics: Animals; Cachexia; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Genes, erbB-1; Head and Neck Neoplasms; Humans; Ligands; Lung Neoplasms; Mice; Parathyroid Hormone-Related Protein; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck	2022
Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome. The American journal of hospice & palliative care, 2013, Volume: 30, Issue:2 Topics: Anorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Parenteral Nutrition; Quinazolines; Syndrome	2013

Article

Year

Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.

Journal of cachexia, sarcopenia and muscle, 2022, Volume: 13, Issue:3

Topics: Animals; Cachexia; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Genes, erbB-1; Head and Neck Neoplasms; Humans; Ligands; Lung Neoplasms; Mice; Parathyroid Hormone-Related Protein; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck

2022

Erlotinib plus parenteral nutrition: an opportunity to get through the hardest days of advanced non-small cell lung cancer with cancer anorexia-cachexia syndrome.

The American journal of hospice & palliative care, 2013, Volume: 30, Issue:2

Topics: Anorexia; Cachexia; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Parenteral Nutrition; Quinazolines; Syndrome

2013